PPP3CA
PPP3CA (protein phosphatase 3 catalytic subunit alpha, also known as CNA1, PPP2B, CALN and CALNA) is the alpha catalytic subunit of calcineurin. It is a calcium-dependent, calmodulin-stimulated serine/threonine phosphatase that transduces intracellular Ca(2+) signals. Browse Assay Genie's current range of PPP3CA research reagents below, or read on for the biology behind the target.
PPP3CA plays an essential role in transducing intracellular Ca(2+)-mediated signals. When Ca(2+) levels rise, this calmodulin-stimulated phosphatase removes phosphate groups from its substrates, many of which contain a PxIxIT motif and/or a LxVP motif. Among them is the transcription factor NFATC1, which PPP3CA dephosphorylates and activates; it regulates NFAT-mediated transcription, probably by promoting NFAT nuclear translocation. It also dephosphorylates and inactivates ELK1, and dephosphorylates and activates SSH1, which leads to cofilin dephosphorylation. Further substrates include DNM1L, HSPB1, DARPP32, TFEB and KLHL3. PPP3CA also negatively regulates SLC9A1 activity and MAP3K14/NIK signalling, by limiting nuclear translocation of RELA and RELB.
The enzyme is a member of the PPP phosphatase family and the PP-2B subfamily, and it is part of the calcineurin complex. Subcellular locations include the cytoplasm, the cell membrane and sarcolemma, the Z line of the sarcomere and dendritic spines. Reported biological roles span kidney development and AQP2 localisation, salivary enzyme secretion, keratinocyte differentiation and survival, osteoblast and osteoclast differentiation, hippocampal homosynaptic depotentiation and antigen-specific T-cell proliferation. The mouse and rat orthologues are both named Ppp3ca.
The HGNC gene group classifies the PPP3CA gene with protein phosphatase catalytic subunits and calcineurin subunits. Earlier nomenclature named it protein phosphatase 3 (formerly 2B), catalytic subunit, alpha isoform (calcineurin A alpha). NCBI Gene reports that variants are implicated in developmental and epileptic encephalopathy 91, and that PPP3CA is a biomarker of cholangiocarcinoma, focal segmental glomerulosclerosis and schizophrenia.
PPP3CA dephosphorylates NFATC1 in response to rising Ca(2+), making it central to calcineurin-NFAT signalling cascades.
It is present in dendritic spines, regulates CACNA1B-mediated Ca(2+) release probability and is required for hippocampal homosynaptic depotentiation.
PPP3CA supports nephrogenic zone development, AQP2 localisation and KLHL3-WNK4 regulation, and is linked to focal segmental glomerulosclerosis.
It promotes osteoblast and osteoclast differentiation and is required for antigen-specific T-cell proliferation responses.
PPP3CA is the catalytic subunit of calcineurin, a Ca(2+)-dependent, calmodulin-stimulated protein phosphatase. It dephosphorylates substrates such as NFATC1, ELK1, DNM1L and SSH1 in response to raised Ca(2+), thereby converting calcium signals into changes in transcription, cytoskeleton and organelle dynamics.
PPP3CA is also called CNA1, PPP2B, CALN and CALNA. Its earlier name was protein phosphatase 3 (formerly 2B), catalytic subunit, alpha isoform, often written calcineurin A alpha. It belongs to the PP-2B subfamily of PPP phosphatases and is a calcineurin subunit.
Orthologues exist in mouse and rat, both named Ppp3ca. NCBI Gene implicates PPP3CA in developmental and epileptic encephalopathy 91 and describes it as a biomarker of cholangiocarcinoma, focal segmental glomerulosclerosis and schizophrenia. Check the datasheet of any product for its validated reactivity.
Calcineurin partners, other PPP-family phosphatase catalytic subunits and related regulatory subunits with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q08209; product specifications from Assay Genie datasheets.